Literature DB >> 7895537

Fatal invasive aspergillosis during cyclosporine and steroids treatment for Crohn's disease.

A Scalzini, C Barni, R Stellini, L Sueri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7895537     DOI: 10.1007/bf02064361

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  4 in total

1.  Pneumocystis carinii pneumonia during cyclosporine therapy for ulcerative colitis.

Authors:  M B Smith; S B Hanauer
Journal:  N Engl J Med       Date:  1992-08-13       Impact factor: 91.245

2.  Cyclosporin treatment for severe active ulcerative colitis.

Authors:  G Bianchi Porro; M Petrillo; S Ardizzone
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

3.  Cyclosporin for the treatment of severe inflammatory bowel disease.

Authors:  K Baker; D P Jewell
Journal:  Aliment Pharmacol Ther       Date:  1989-04       Impact factor: 8.171

4.  Preliminary report: cyclosporin in treatment of severe active ulcerative colitis.

Authors:  S Lichtiger; D H Present
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

  4 in total
  4 in total

Review 1.  Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature.

Authors:  Joel W Alderson; Thomas G Van Dinter; Michael J Opatowsky; Elizabeth C Burton
Journal:  MedGenMed       Date:  2005-09-21

Review 2.  Comparative tolerability of treatments for inflammatory bowel disease.

Authors:  R B Stein; S B Hanauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

3.  Insulin and gall stones: a population case control study in southern Italy.

Authors:  G Misciagna; V Guerra; A Di Leo; M Correale; M Trevisan
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

Review 4.  Cyclosporine and inflammatory bowel disease: buying time.

Authors:  M A Meijssen
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.